| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/2004 | US20040191330 Daily skin care regimen |
| 09/30/2004 | US20040191329 Antimicrobial, atomically disordered, nanocrystalline silver components; greater penetration, coverage, efficacy |
| 09/30/2004 | US20040191327 Increasing interferon-gamma and decreasing IL-5, IL-4, and IgE levels to normal; preventing airway constriction and hyperreactivity; no side effects |
| 09/30/2004 | US20040191326 Taste-masking vehicle for coated oxazolidinone particles |
| 09/30/2004 | US20040191322 Physically and chemically stable nicotine-containing particulate material |
| 09/30/2004 | US20040191315 Office products containing antimicrobial agent |
| 09/30/2004 | US20040191312 Preventing reperfusion injury following stroke; restoring brain cell function; 1-(m-chlorophenyl)-biguanide, N-phenyl-imidocarbonimidicdiamide, 2-methyl-5-hydroxytryptaminemaleate, 2-(1-(4-methyl)-piperazineyl)quinolinedimaleate and/or 1-(6-chloro-2-pyridinyl)-4-piperidinamine |
| 09/30/2004 | US20040191311 Use of methyltestosterone as a drug for treatment of human papilloma virus infections |
| 09/30/2004 | US20040191310 Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases |
| 09/30/2004 | US20040191309 Trans-tetracos-15-enoic acid and andrographolide; nontoxic, side effect free |
| 09/30/2004 | US20040191298 Oral pharmaceuticals combined with cocoa butter; taste masking; rapid mouth disintegration delivery without fluid consumption |
| 09/30/2004 | US20040191297 Carotenoid formulation |
| 09/30/2004 | US20040191295 Preventing rotavirus induced diarrhea; lactulose |
| 09/30/2004 | US20040191294 Health composition |
| 09/30/2004 | US20040191282 Hemectant and cosmetics and internal preparations containing the same |
| 09/30/2004 | US20040191278 Enhancing dermal collagen production; wrinkle treatment; vasodilation with nicotinic acid and irradiation |
| 09/30/2004 | US20040191276 Compositions and kits for compounding pharmaceuticals |
| 09/30/2004 | US20040191274 Topical composition |
| 09/30/2004 | US20040191263 Enteral compositions for the prevention and/or treatment of sepsis |
| 09/30/2004 | US20040191254 Administering compound to decrease epidermal growth factor activity; anticarcinogenic agents for thyroid cancer mediated by mutations in RET gene |
| 09/30/2004 | US20040191251 Rescue of gonadotropin releasing hormone receptor mutants |
| 09/30/2004 | US20040191247 Use of il-18 inhibitors for treating or preventing cns injuries |
| 09/30/2004 | US20040191239 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 09/30/2004 | US20040191238 Administering to patient an agent which triggers anion efflux in respiratory tissues via activation of a secretin receptor |
| 09/30/2004 | US20040191237 Mixture of proteases from Aspergillus oryzae and Bacillus subtilis and an Aspergillus niger lipase; indigestion, sour stomach, dyspepsia, and other gastrointestinal disorders related to poor protein digestion |
| 09/30/2004 | US20040191234 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/30/2004 | US20040191223 Combinatorial methods for inducing cancer cell death |
| 09/30/2004 | US20040191218 Pharmaceutical compositions and methods for treating cancer |
| 09/30/2004 | US20040191214 Nucleoside vaccine adjuvants |
| 09/30/2004 | US20040191213 Method of bowel cleansing |
| 09/30/2004 | US20040191212 Phosphate-binding polymers for oral administration |
| 09/30/2004 | US20040191211 Tissue-specific transporter inhibitor |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | US20040191209 Drugs for ameliorating postcibal hyperglycemia |
| 09/30/2004 | US20040191207 Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| 09/30/2004 | US20040191206 Methods for reduction of inflammation and erythema |
| 09/30/2004 | US20040191202 Methods of promoting hair growth |
| 09/30/2004 | US20040191196 Novel conjugate compounds and dermatological compositions thereof |
| 09/30/2004 | US20040191186 Porous particles comprising excipients for deep lung delivery |
| 09/30/2004 | US20040191185 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 09/30/2004 | US20040191184 Delivery of muscle relaxants through an inhalation route |
| 09/30/2004 | US20040191183 Delivery of antiemetics through an inhalation route |
| 09/30/2004 | US20040191182 Delivery of analgesics through an inhalation route |
| 09/30/2004 | US20040191181 Vaporization of diphenhydramine from solid for breathing administerig |
| 09/30/2004 | US20040191180 Breathing analgesics after vaporization for administering pain killer for headaches |
| 09/30/2004 | US20040191179 Breathing antidepressants from aerosols for administering bupropion by heating on a solid support |
| 09/30/2004 | US20040191178 Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| 09/30/2004 | US20040191177 Solutions with glycerol or sorbitol and adjuvants with active material |
| 09/30/2004 | US20040191176 Bronchodilator, vasoconstrictor, corticosteroid and optional carrier and drug delivery device for lungs |
| 09/30/2004 | US20040191175 Radio-Opaque polymer biomaterials |
| 09/30/2004 | US20040191172 Preventive or therapeutic agents for dermatitis or alopecia, evaluation method of the agents, and transgenic mouse |
| 09/30/2004 | US20040191168 Tumor cell killing by cell cycle checkpoint abrogation combined with Inhibition of the classical mitogen activated protein (map) kinase pathway |
| 09/30/2004 | US20040191044 Systems, methods and apparatuses for manufacturing dosage forms |
| 09/30/2004 | US20040188316 Oral administering; blister card; dosage cycles;mixture of calcium and vitamin d |
| 09/30/2004 | US20040187865 Metered dose inhaler for fluticasone propionate |
| 09/30/2004 | DE10312809A1 Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern Pramipexole to reduce excessive food intake in children |
| 09/30/2004 | DE10312346A1 Kontrolliertes Freisetzungssystem Controlled release system |
| 09/30/2004 | DE10312061A1 Kombination von Phenylcarbonsäureamiden mit Blockern des IK-Kanals und deren Verwendung zur Behandlung von Vorhofarrhythmien Combination of phenylcarboxamides with the IK channel blockers and their use for the treatment of atrial arrhythmias |
| 09/30/2004 | DE10312000A1 Ethercarbonsäureester von Sterolen bzw. Stanolen Ethercarbonsäureester of sterols or stanols |
| 09/30/2004 | DE10311729A1 Endovaskuläres Implantat mit einer mindestens abschnittsweisen aktiven Beschichtung aus Ratjadon und/oder einem Ratjadon-Derivat The endovascular graft with an at least piecewise active coating of ratjadone and / or a derivative ratjadone |
| 09/30/2004 | DE10260882A1 Dosieraerosole mit Lecithin als oberflächenaktiver Substanz MDIs containing lecithin as surfactant |
| 09/30/2004 | DE10259004B4 11β-substituierte Steroide, als Glucocorticoid-Rezeptorantagonisten und deren Verwendung 11β-substituted steroids as glucocorticoid receptor antagonists and the use thereof |
| 09/30/2004 | DE10255236A9 Teigwaren, zB Nudeln, mit verkürzter Koch-/Garzeit umfassend cellulosehaltiges Material, insbesondere Getreidefasern Pasta, such as noodles, with a shorter cooking / cooking comprising cellulosic material, especially cereal fiber |
| 09/30/2004 | DE10202468A1 Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung Pteridine derivatives, processes for their preparation and their use |
| 09/30/2004 | CA2855229A1 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 09/30/2004 | CA2633287A1 Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases |
| 09/30/2004 | CA2524255A1 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
| 09/30/2004 | CA2522176A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | CA2519853A1 Process for the preparation of 7-amino (p-hydroxyphenylglycylamido) cephem compounds |
| 09/30/2004 | CA2519584A1 Pramipexole for reducing excessive food intake by children |
| 09/30/2004 | CA2519582A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | CA2519490A1 Polymorphis of valsartan |
| 09/30/2004 | CA2519458A1 Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 09/30/2004 | CA2519444A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519442A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519439A1 Compositions and methods for treating colic |
| 09/30/2004 | CA2519434A1 Nucleotide lipid ester derivatives |
| 09/30/2004 | CA2519429A1 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
| 09/30/2004 | CA2519414A1 Methods of treating inflammatory diseases associated with bone destruction |
| 09/30/2004 | CA2519372A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519357A1 Treatment of type 1 diabetes with pde5 inhibitors |
| 09/30/2004 | CA2519310A1 Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor |
| 09/30/2004 | CA2519289A1 Nemorubicin as radiosensitizer in combination with radiation therapy against tumors |
| 09/30/2004 | CA2519250A1 Therapeutic agent for diabetes mellitus |
| 09/30/2004 | CA2519211A1 Release control compositions |
| 09/30/2004 | CA2519126A1 Improved bioavailability and improved delivery of acidic pharmaceutical drugs |
| 09/30/2004 | CA2519125A1 Dispersible formulation of an anti-inflammatory agent |
| 09/30/2004 | CA2519092A1 Branched water-soluble polymers and their conjugates |
| 09/30/2004 | CA2519026A1 Therapeutic and/or preventive agent for chronic skin disease |
| 09/30/2004 | CA2519023A1 Facially amphiphilic polymers and oligomers and uses thereof |
| 09/30/2004 | CA2519002A1 Phenylcarboxyl acid amides and ikr channel inhibitors combination and the use thereof for treating atrial arrhythmia |
| 09/30/2004 | CA2518973A1 Methods for isolating crystalline form i of 5-azacytidine |
| 09/30/2004 | CA2518968A1 Drug composition with antimicrobial activity |
| 09/30/2004 | CA2518836A1 Drug formulations having long and medium chain triglycerides |
| 09/30/2004 | CA2518834A1 Oxycodone conjugates with lower the abuse potential and extended duration of action |
| 09/30/2004 | CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2518679A1 Guanidine derivatives and use thereof as neuropeptide ff receptor antagonists |
| 09/30/2004 | CA2518658A1 Composition and method for appetite and craving suppression and mood enhancement |
| 09/30/2004 | CA2518655A1 Retinoid replacements and opsin agonists and methods for the use thereof |